HomePPCB • NASDAQ
add
Propanc Biopharma Inc
Previous close
$0.81
Day range
$0.78 - $0.83
Year range
$0.73 - $9.36
Market cap
10.52M USD
Avg Volume
311.00K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.67M | 1,507.20% |
Net income | -4.84M | -1,265.40% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.67M | -1,507.56% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 602.74K | 6,403.42% |
Total assets | 17.98M | 28,144.11% |
Total liabilities | 3.61M | -13.36% |
Total equity | 14.36M | — |
Shares outstanding | 13.36M | — |
Price to book | 0.72 | — |
Return on assets | -62.14% | — |
Return on capital | -76.14% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -4.84M | -1,265.40% |
Cash from operations | -1.94M | -723.33% |
Cash from investing | -2.49K | — |
Cash from financing | 2.53M | 1,071.43% |
Net change in cash | 590.65K | 5,098.30% |
Free cash flow | -108.34K | -1,210.41% |
About
Founded
2007
Website
Employees
2
